Organogenesis Holdings (ORGO) Capital Leases (2017 - 2026)

Organogenesis Holdings' Capital Leases history runs 9 years deep, the most recent figure standing at $12.4 million for Q1 2026.

• In Q1 2026, Capital Leases rose 2906.81% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $12.4 million (up 2906.81% YoY), while the FY2025 annual figure was $12.8 million, up 1681.06% from the prior year.
• Capital Leases was $12.4 million for Q1 2026 at Organogenesis Holdings, down from $12.8 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $12.8 million in Q4 2025 to a low of $98000.0 in Q2 2025.
• Historically, Capital Leases has averaged $3.1 million across 4 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Capital Leases plunged 92.54% in 2025, then jumped 2906.81% in 2026.
• A 4-year view of Capital Leases shows it stood at $1.9 million in 2023, then sank by 61.97% to $718000.0 in 2024, then jumped by 1681.06% to $12.8 million in 2025, then decreased by 3.36% to $12.4 million in 2026.
• The last three Capital Leases figures came in at $12.4 million (Q1 2026), $12.8 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.